Pregabalin Capsule 75 mg (Pregabalin)

Adult dose

This medication is administered orally, divided into two doses per day, regardless of food. 1. Neuropathic pain Peripheral neuropathic pain: The starting dose is 150 mg per day, which can be increased to 300 mg per day within 3 to 7 days, and if necessary, increased up to a maximum of 600 mg per day in 7-day intervals. Central neuropathic pain: The starting dose is 150 mg per day, increased to 300 mg after a week.

Child dose

Safety and efficacy data are insufficient for patients under 12 years of age and adolescents aged 12 to 17, thus administration is not recommended.

This medication may increase the risk of suicidal thoughts or behaviors, so if symptoms of depression or mood changes occur during treatment, immediate consultation with a healthcare professional is required. Patients with hypersensitivity to this medication should not take it. Patients with diabetes may need to adjust their blood sugar control medications due to potential weight gain. If symptoms of angioedema occur, the medication should be discontinued immediately, as swelling of the face or around the mouth may develop. Elderly patients are at risk of falls or injuries due to dizziness or drowsiness while taking this medication, so caution is advised. Blurred vision or changes in eyesight may occur, and if symptoms arise, consultation with a healthcare professional is necessary. Discontinuing this medication abruptly may result in withdrawal symptoms such as insomnia, headache, nausea, and anxiety, so the dosage should be gradually reduced as per medical guidance. Due to the risk of drug abuse, patients with a history of substance abuse should be particularly careful and report any unusual behaviors immediately. Patients with impaired renal function may require dosage adjustments. Patients with heart conditions should exercise caution when taking this medication. Risk of central nervous system depression increases when taken with opioids, so caution is warranted when co-administered. Patients with compromised respiratory function or elderly patients may be at risk of severe respiratory depression, so dosage may need to be adjusted. In early pregnancy, there may be risks to the fetus, thus women who are pregnant or planning to become pregnant should definitely consult before taking this medication. Breastfeeding women should discuss with healthcare professionals about the medication being passed into breast milk. Caution is necessary when driving or operating machinery due to the risk of dizziness and drowsiness leading to accidents. Overdose may lead to symptoms such as drowsiness, confusion, and depression, and may require treatments such as blood dialysis if necessary. It should be stored out of reach of children and it is safer not to transfer it to other containers.

Serious side effects

Hives, severe swelling (edema), angioedema, chest tightness, difficulty breathing, cold sweat, pallor, severe rash accompanied by fever, blisters, skin peeling, pain in mouth/eye mucous membranes, Stevens-Johnson syndrome, toxic epidermal necrolysis, shortness of breath or difficulty breathing, asthma attacks, cough with fever and respiratory abnormalities, yellowing of skin or eyes (jaundice), extreme lethargy, liver abnormalities (jaundice), sudden and severe

Mild side effects

• Dizziness
• drowsiness
• confusion
• disturbances in sense of direction
• irritability
• depression
• euphoria
• decreased libido
• insomnia
• depersonalization

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. The appropriate storage temperature is room temperature between 15 to 30 degrees Celsius, avoiding excessively hot or cold places.

Appearance

A hard capsule with a reddish-brown upper body and a white lower body containing white powder.

Package unit

30 capsules/bottle, 100 capsules/bottle